iiinova — where your digital self keeps evolving

UChicago Cancer @uchicagocancer.bsky.social · 01/10/2026

A free, in-person HCC Lunch & Learn on October 24, 2026, at UChicago Medicine will provide critical education about liver health, liver disease, and hepatocellular carcinoma (HCC). Learn more and register: www.bluefaery.org/hcc-lunch-le... #LiverCancer #CancerPrevention

000

UChicago Cancer @uchicagocancer.bsky.social · 01/10/2026

October marks #BreastCancerAwarenessMonth! The 5-year survival rate is nearly 100% when breast cancer is caught early. UChicago Medicine offers mammograms at 12 convenient locations. Don't wait, schedule your appointment today. #EarlyDetectionSavesLives ow.ly/X1oA50ZTzOr

000

UChicago Cancer @uchicagocancer.bsky.social · 30/09/2026

Huge congratulations to Dr. Ernst Lengyel on receiving 2026 Lotus Award!🎉 This award will support Dr. Lengyel's research studying how metabolism reprogram ovarian cancer cells to unlock new targeted therapies. #OvarianCancer @uchicagomedicine.bsky.social ow.ly/x9zV50ZT8uq

000

UChicago Cancer @uchicagocancer.bsky.social · 29/09/2026

THIS SATURDAY: Cap's Ice Cream in Mount Prospect is hosting a fundraiser to support the American Cancer Society Making Strides Against Breast Cancer walk.

001

UChicago Cancer @uchicagocancer.bsky.social · 29/09/2026

The new KRAS inhibitors look promising, but Dr. Ratain, and co-authors argue that oncology is still not doing enough to prove that patients are receiving the lowest effective dose with the fewest possible side effects. University of Michigan @uchicagomedicine.bsky.social ow.ly/y2zo50ZSMx1

000

UChicago Cancer @uchicagocancer.bsky.social · 26/09/2026

October is #BreastCancerAwarenessMonth! Join us for a webinar series featuring University of Chicago Medicine faculty to discuss key topics in #breastcancer, including screening, prevention, & research! #breastcancerawareness #breastcancerresearch #breastcancerprevention #breastcancerscreening

000

UChicago Cancer @uchicagocancer.bsky.social · 26/09/2026

000

UChicago Cancer @uchicagocancer.bsky.social · 25/09/2026

A phase 1 trial led by Michael Bishop, MD, at UChicago Medicine and investigators at Mass General Brigham Cancer Institute, found that investigational BCMA-targeted CAR-T therapy anito-cel produced deep, durable responses in relapsed/refractory multiple myeloma. ow.ly/agH950ZRalu

000

UChicago Cancer @uchicagocancer.bsky.social · 24/09/2026

🔥Hot off the press: Michael Bishop, MD, and colleagues report results from the phase 1 study of anito-cel, a BCMA-directed CAR T-cell therapy, showing encouraging activity in heavily pretreated relapsed/refractory multiple myeloma. NEJM.org @uchicagomedicine.bsky.social ow.ly/itRY50ZR8qu

010

UChicago Cancer @uchicagocancer.bsky.social · 24/09/2026

On this #WorldCancerResearchDay, together with researchers, clinicians, patients, and partners, we remain committed to advancing knowledge, accelerating innovation, and improving cancer outcomes for all. #AdvancingCancerResearchTogether @uchicagomedicine.bsky.social ow.ly/4bq150ZQQaq

000

UChicago Cancer @uchicagocancer.bsky.social · 23/09/2026

At a recent US Prostate Cancer Consensus Conference, Drs. Russell Szmulewitz and Rahul Aggarwal shared insights on the use of PARP inhibitor beyond BRCA2, and how to balance efficacy with long-term toxicity. @uchicagomedicine.bsky.social UCSF Health Listen here: ow.ly/PNUp50ZQJZA

000

UChicago Cancer @uchicagocancer.bsky.social · 22/09/2026

How Do I Know if a Clinical Trial Is Right for Me? A comic explaining the risks and benefits of participating in a cancer clinical trial, translated for a Mandarin-speaking audience.

000

UChicago Cancer @uchicagocancer.bsky.social · 21/09/2026

In a new study published in Molecular Cell, Chuan He, PhD, and colleagues reveal that 5-azaC, a drug used to treat blood cancers, works through a previously underappreciated mechanism involving RNA methylation rather than just DNA effects. @uchichemistry.bsky.social ow.ly/P0Lg50ZPMq2

000

UChicago Cancer @uchicagocancer.bsky.social · 17/09/2026

🔥Hot off the press: A new study in Cancer Cell from Dr. Weichselbaum and colleagues show how high-dose radiation increases TET2 expression, activating immunosuppressive MDSCs to drive tumor progression. @uchicagomedicine.bsky.social ow.ly/zj6J50ZOR6z

000

UChicago Cancer @uchicagocancer.bsky.social · 17/09/2026

September marks #ChildhoodCancerAwarenessMonth! At Comer Children's Hospital, cancer care goes beyond diagnosis and treatment. The UChicago Medicine Childhood Cancer Survivors Center helps prevent, and treat long-term issues associated with cancer therapy. #SurvivorCare ow.ly/geK850ZOQ3c

000

UChicago Cancer @uchicagocancer.bsky.social · 16/09/2026

September is #GynecologicCancerAwarenessMonth! Join us next Thursday, 9/24 for a webinar featuring Dr. Kelsea Grant for a conversation about gynecologic cancer screening, symptoms, treatment, & more! Date: Thursday, 9/24 Time: 12:00-1:00 PM CT RSVP: qrco.de/GYNCancers26

000

UChicago Cancer @uchicagocancer.bsky.social · 16/09/2026

NIH-funded discoveries have transformed millions of lives with cancer. Sustained federal funding is essential to protect progress, support future cancer research, and advance the mission to end cancer. #CancerProgressReport American Association for Cancer Research (AACR)‬ ow.ly/BMZR50ZOjKf

000

UChicago Cancer @uchicagocancer.bsky.social · 16/09/2026

Maintaining a healthy lifestyle through regular exercise, a balanced diet, and avoiding tobacco and alcohol remain some of the most effective strategies for reducing cancer risk. American Association for Cancer Research (AACR)‬ #ProgressReport #ModifiableRiskFactors #CancerRisk ow.ly/BMZR50ZOjKf

000

UChicago Cancer @uchicagocancer.bsky.social · 16/09/2026

Breakthrough discoveries and technological advances are driving better strategies to reduce the risk of developing cancer and detect cancer at the earliest possible stage. American Association for Cancer Research (AACR)‬ #CancerProgressReport ow.ly/Ry0z50ZOk8r

000

UChicago Cancer @uchicagocancer.bsky.social · 16/09/2026

Unprecedented advances in cancer treatment and care have led to more people living longer and fuller lives after a cancer diagnosis. According to the 2026 AACR #CancerProgressReport, the number of survivors is projected to exceed 22 million by 2035. @theaacr.bsky.social‬ ow.ly/BMZR50ZOjKf

000

UChicago Cancer @uchicagocancer.bsky.social · 15/09/2026

Our staff went on a field trip to tour Hyde Park Labs, a 300,000-sq-ft commercial laboratory facility designed to accommodate state-of-the-art research and entrepreneurship on Chicago's South Side.

010

UChicago Cancer @uchicagocancer.bsky.social · 14/09/2026

A critical question in cancer care is: Will this treatment work? Marina Garassino, MD, a lung cancer expert at UChicago, collaborated with six centers worldwide to integrate multiple advanced NSCLC data types and apply AI tools to predict treatment response. #13LungProject ow.ly/pNmy50ZNuMh

ow.ly

AI tool successfully predicts outcomes of immunotherapy in lung cancer - UChicago Medicine

Artificial intelligence tools can help physicians predict treatment and survival outcomes in patients with advanced non-small cell lung cancer treated with immunotherapy.

000

UChicago Cancer @uchicagocancer.bsky.social · 14/09/2026

For cancer treatment, a tumor biopsy is often critical. But biopsies are risky in complex areas like brainstem. Mariam Hammoud trusted neurosurgery experts at the University of Chicago to get her tumor biopsy. Now she is leading an active life. @uchicagomedicine.bsky.social ow.ly/iiut50ZNu84

000

UChicago Cancer @uchicagocancer.bsky.social · 11/09/2026

The AbbVie Foundation Cancer Pavilion is set to open in 2027! Every corner of the pavilion has been thoughtfully designed to create a deeply comfortable experience for patients and their families throughout their visit. Read more about the pavilion here: ow.ly/tsOB50ZMEab

000

UChicago Cancer @uchicagocancer.bsky.social · 10/09/2026

Cancer diagnosis and treatment decisions heavily rely on pathology images, CT scans, gene expression, and other biological data. Learn how Alex Pearson, MD, PhD, uses HPC to decode complex cancer biomarkers and inform treatment decisions. @uchicagomedicine.bsky.social ow.ly/S17850ZLZsF

000

UChicago Cancer @uchicagocancer.bsky.social · 09/09/2026

The Y-Me Softball Tournament on 8/29 had its biggest attendance yet. Funds raised from the event support breast cancer research in the lab of Kay Macleod at UChicago. Thanks to all who participated!

000

UChicago Cancer @uchicagocancer.bsky.social · 08/09/2026

On this #ChildhoodCancerAwarenessMonth, we honor children and families affected by cancer and recognize the UChicago Cancer researcher's role in turning shared data into discoveries that advance pediatric cancer care. @UChicagoMed @ComerChildrens #DataCommons #Neuroblastoma ow.ly/bnER50ZJBWk

000

UChicago Cancer @uchicagocancer.bsky.social · 04/09/2026

We are thrilled to congratulate Mary Dolan, PhD, on being selected for the 2026 Department of Medicine Arthur Rubenstein Mentorship Award! This well-deserved recognition reflects her exceptional dedication to mentoring and her lasting impact on the UChicago Medicine. @uchicagomedicine.bsky.social

000

UChicago Cancer @uchicagocancer.bsky.social · 03/09/2026

In a recent JAMA editorial, Dr. Stanley Liauw highlights how prostate cancer radiation therapy is evolving to better balance cancer control, quality of life and patient-centered care. #ProstateCancer #RadiationOncology #CancerResearch ow.ly/rmZa50ZIYtE

011

UChicago Cancer @uchicagocancer.bsky.social · 03/09/2026

September is #ProstateCancerAwarenessMonth! Join the University of Chicago Medicine Comprehensive Cancer Center for a webinar about the Prostate Cancer Focal Therapy led by Dr. Abhinav Sidana. Date: Wed, 9/9 Time: 1:00-2:00 PM CT RSVP: qrco.de/prostate26

000

UChicago Cancer @uchicagocancer.bsky.social · 03/09/2026

Welcome inside Jeff Rathmell's laboratory at the University of Chicago. Spenser Stone, a PhD student, explains how the lab is studying immune cell and cancer cell metabolism. Video narrated by Amelie Momgbet, a college student in our Chicago EYES on Cancer pathway program. #CancerResearch #PhDLife

000

UChicago Cancer @uchicagocancer.bsky.social · 03/09/2026

September is Blood Cancer Awareness Month. At UChicago Medicine, we honor everyone impacted by leukemia, lymphoma, and multiple myeloma, while advancing research, clinical trials and innovative treatments that bring hope to patients and families. Learn more here: ow.ly/6Bh750ZIU4Q

000

UChicago Cancer @uchicagocancer.bsky.social · 03/09/2026

Family and friends of our pathway program students joined us at UChicago for an evening filled with interactive science demonstrations (including strawberry DNA extraction), lab experiences, and opportunities to learn more about the research happening at UChicago.

000

UChicago Cancer @uchicagocancer.bsky.social · 02/09/2026

Amelie Momgbet, a student working in @marinagarassino.bsky.social lab presented work on whether AI could predict lung cancer mutations at the 12th Annual Summer Research Symposium. Amelie took part in Chicago EYES on Cancer, a research training program for high school and college students.

000

UChicago Cancer @uchicagocancer.bsky.social · 01/09/2026

Comer Children's recently received a $100,000 Impact Grant from Hyundai Hope on Wheels to support pediatric cancer research. Pictured is Dr. James LaBelle, who provides care for children of all ages with cancer and blood diseases, including leukemia and lymphoma.

000

UChicago Cancer @uchicagocancer.bsky.social · 31/08/2026

🔥Hot off the press: A new Molecular Cell study reveals that WDR5 broadly binds RNA to reshape the MLL1/KMT2A chromatin-modifying complex, offering insight into how RNA-mediated regulation of chromatin state may influence leukemia development. ow.ly/A4RY50ZHtFX

ow.ly

RNA creates a self-destruct switch for cellular machinery linked to leukemia

UChicago researchers found that the MLL1 complex binds RNA indiscriminately — and that the RNA it helps produce eventually pulls the complex apart.

000

UChicago Cancer @uchicagocancer.bsky.social · 31/08/2026

A new multicenter GASTRIC consortium study identify that the absence of unusual endoscopic findings may be reassuring; masses, thickened folds, and signet ring cell carcinoma indicate higher risk of advanced disease in CDH1 carriers. @soniakupfer.bsky.social pubmed.ncbi.nlm.nih.gov/42604658

000

UChicago Cancer @uchicagocancer.bsky.social · 31/08/2026

Researchers at the University of Chicago developed AI tools to understand how tumor cells and their gene activity are organized in the tumor microenvironment, helping predict treatment response. Cell Reports Medicine University of Chicago Pathology ow.ly/gE0L50ZHkMw

010

UChicago Cancer @uchicagocancer.bsky.social · 28/08/2026

Join us for a webinar about Cholangiocarcinoma, a rare bile duct cancer, with Melinda Bachini, Chief Patient Officer of the Cholangiocarcinoma Foundation. Date: Tuesday, September 1st Time: 12:00-1:00 PM CT RSVP: qrco.de/cholangiocarcinoma26 #cholangiocarcinoma #cancereducation

011

UChicago Cancer @uchicagocancer.bsky.social · 28/08/2026

In a new Nature Biotechnology article, Mark Ratain, MD, and co-authors examines how minor changes to existing cancer drugs may extend market exclusivity without clear innovation, highlighting the need for patent policies that protect patients and scientific progress. ow.ly/YyJY50ZGG5e

000

UChicago Cancer @uchicagocancer.bsky.social · 27/08/2026

Kick off Breast Cancer Awareness Month on 9/17 for Rise & Thrive breast cancer survivor panel discussion and breakfast. Dr. Sarah Shubeck will moderate and provide an update on the future of breast cancer research. e.givesmart.com/events/PtE

000

UChicago Cancer @uchicagocancer.bsky.social · 27/08/2026

The 5th Annual South Side Science Festival takes place Saturday, October 3. Come visit "Cancer Corner" to participate in demos and learn about cancer research that helps patients live healthier lives. DETAILS: southsidescience.event.uchicago.edu

000

UChicago Cancer @uchicagocancer.bsky.social · 26/08/2026

Huang et al. reports progressive brainstem necrosis after standard radiation therapy in pineoblastoma with 22q11.2 deletion, suggesting increased susceptibility to radiation-induced normal tissue injury. #GeneticMutations #BrainCancer #RadiationTherapy pubmed.ncbi.nlm.nih.gov/42612869

000

UChicago Cancer @uchicagocancer.bsky.social · 25/08/2026

How Do I Know if a Clinical Trial Is Right for Me? A comic explaining the risks and benefits of participating in a cancer clinical trial, translated for an Arabic-speaking audience.

000